Columnist Caroline Gainer weighs in on how changes with her doctors have affected her ability to coordinate care for her COPD ...

Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD ...

Fatigue is one of the most common symptoms of COPD, so it's important to understand what causes it, columnist Caroline Gainer says.

Predicting COPD exacerbations In a pilot study, Drummond and his colleagues examined whether the ProAir Digihaler can help predict an impending COPD exacerbation. The researchers remotely enrolled 55 ...

Yupelri (revefenacin) is an approved once-daily maintenance therapy developed by Theravance Biopharma and Mylan (now part of Viatris) for chronic obstructive pulmonary disease (COPD). Its U.S.

COPD News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for ...

Abrysvo was already cleared in the U.S. for adults older than 60 and pregnant people at 32-36 weeks of gestation to protect infants from birth to age 6 months. With the new authorization, Abrysvo ...

The Verona Pharma therapy, with a list price of $2,950 for a monthly supply, was cleared by the U.S. Food and Drug Administration in June as an inhaled maintenance therapy for adults with COPD. “We ...

In the late 1960s and early ’70s, nearly all of the steel mills in the upper Ohio Valley were fueled by metallurgical coal. That kind of coal is used to make coke, a pure form of carbon that fuels the ...